首页 > 最新文献

Acta Neuropathologica最新文献

英文 中文
Epigenetic and genetic risk of Alzheimer disease from autopsied brains in two ethnic groups 从两个种族群体的尸检大脑看阿尔茨海默病的表观遗传和遗传风险。
IF 9.3 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-08-23 DOI: 10.1007/s00401-024-02778-y
Yiyi Ma, Dolly Reyes-Dumeyer, Angel Piriz, Patricia Recio, Diones Rivera Mejia, Martin Medrano, Rafael A. Lantigua, Jean Paul G. Vonsattel, Giuseppe Tosto, Andrew F. Teich, Benjamin Ciener, Sandra Leskinen, Sharanya Sivakumar, Michael DeTure, Duara Ranjan, Dennis Dickson, Melissa Murray, Edward Lee, David A. Wolk, Lee-Way Jin, Brittany N. Dugger, Annie Hiniker, Robert A. Rissman, Richard Mayeux, Badri N. Vardarajan

Genetic variants and epigenetic features both contribute to the risk of Alzheimer’s disease (AD). We studied the AD association of CpG-related single nucleotide polymorphisms (CGS), which act as a hub of both the genetic and epigenetic effects, in Caribbean Hispanics (CH) and generalized the findings to Non-Hispanic Whites (NHW). First, we conducted a genome-wide, sliding-window-based association with AD, in 7,155 CH and 1,283 NHW participants. Next, using data from the dorsolateral prefrontal cortex in 179 CH brains, we tested the cis- and trans-effects of AD-associated CGS on brain DNA methylation to mRNA expression. For the genes with significant cis- and trans-effects, we investigated their enriched pathways. We identified six genetic loci in CH with CGS dosage associated with AD at genome-wide significance levels: ADAM20 (Score = 55.19, P = 4.06 × 10–8), the intergenic region between VRTN and SYNDIG1L (Score = − 37.67, P = 2.25 × 10–9), SPG7 (16q24.3) (Score = 40.51, P = 2.23 × 10–8), PVRL2 (Score = 125.86, P = 1.64 × 10–9), TOMM40 (Score = − 18.58, P = 4.61 × 10–8), and APOE (Score = 75.12, P = 7.26 × 10–26). CGSes in PVRL2 and APOE were also significant in NHW. Except for ADAM20, CGSes in the other five loci were associated with CH brain methylation levels (mQTLs) and CGSes in SPG7, PVRL2, and APOE were also mQTLs in NHW. Except for SYNDIG1L (P = 0.08), brain methylation levels in the other five loci affected downstream mRNA expression in CH (P < 0.05), and methylation at VRTN and TOMM40 were also associated with mRNA expression in NHW. Gene expression in these six loci were also regulated by CpG sites in genes that were enriched in the neuron projection and glutamatergic synapse pathways (FDR < 0.05). DNA methylation at all six loci and mRNA expression of SYNDIG1 and TOMM40 were significantly associated with Braak Stage in CH. In summary, we identified six CpG-related genetic loci associated with AD in CH, harboring both genetic and epigenetic risks. However, their downstream effects on mRNA expression maybe ethnic specific and different from NHW.

遗传变异和表观遗传特征都会增加阿尔茨海默病(AD)的患病风险。CpG 相关单核苷酸多态性(CGS)是遗传和表观遗传效应的枢纽,我们研究了加勒比海西班牙裔人(CH)中 CpG 相关单核苷酸多态性与老年痴呆症的关联,并将研究结果推广到非西班牙裔白人(NHW)。首先,我们在 7,155 名加勒比海西班牙裔人和 1,283 名非西班牙裔白人中进行了基于滑动窗口的全基因组AD关联研究。接着,我们利用 179 名 CH 大脑背外侧前额叶皮层的数据,测试了与 AD 相关的 CGS 对大脑 DNA 甲基化和 mRNA 表达的顺式和反式影响。对于具有显著顺式和反式效应的基因,我们研究了其富集通路。我们在CGS剂量与AD相关的CH中发现了6个具有全基因组显著性水平的基因位点:ADAM20(得分 = 55.19,P = 4.06 × 10-8)、VRTN 和 SYNDIG1L 之间的基因间区域(得分 = - 37.67,P = 2.25 × 10-9)、SPG7(16q24.3)(得分 = 40.51,P = 2.23 × 10-8)、PVRL2(得分 = 125.86,P = 1.64 × 10-9)、TOMM40(得分 = - 18.58,P = 4.61 × 10-8)和 APOE(得分 = 75.12,P = 7.26 × 10-26)。在 NHW 中,PVRL2 和 APOE 的 CGS 也很显著。除 ADAM20 外,其他五个位点的 CGS 与 CH 脑甲基化水平相关(mQTLs),SPG7、PVRL2 和 APOE 的 CGS 也是 NHW 的 mQTLs。除 SYNDIG1L 外(P = 0.08),其他五个基因位点的脑甲基化水平均影响 CH 的下游 mRNA 表达(P = 0.05)。
{"title":"Epigenetic and genetic risk of Alzheimer disease from autopsied brains in two ethnic groups","authors":"Yiyi Ma,&nbsp;Dolly Reyes-Dumeyer,&nbsp;Angel Piriz,&nbsp;Patricia Recio,&nbsp;Diones Rivera Mejia,&nbsp;Martin Medrano,&nbsp;Rafael A. Lantigua,&nbsp;Jean Paul G. Vonsattel,&nbsp;Giuseppe Tosto,&nbsp;Andrew F. Teich,&nbsp;Benjamin Ciener,&nbsp;Sandra Leskinen,&nbsp;Sharanya Sivakumar,&nbsp;Michael DeTure,&nbsp;Duara Ranjan,&nbsp;Dennis Dickson,&nbsp;Melissa Murray,&nbsp;Edward Lee,&nbsp;David A. Wolk,&nbsp;Lee-Way Jin,&nbsp;Brittany N. Dugger,&nbsp;Annie Hiniker,&nbsp;Robert A. Rissman,&nbsp;Richard Mayeux,&nbsp;Badri N. Vardarajan","doi":"10.1007/s00401-024-02778-y","DOIUrl":"10.1007/s00401-024-02778-y","url":null,"abstract":"<div><p> Genetic variants and epigenetic features both contribute to the risk of Alzheimer’s disease (AD). We studied the AD association of CpG-related single nucleotide polymorphisms (CGS), which act as a hub of both the genetic and epigenetic effects, in Caribbean Hispanics (CH) and generalized the findings to Non-Hispanic Whites (NHW). First, we conducted a genome-wide, sliding-window-based association with AD, in 7,155 CH and 1,283 NHW participants. Next, using data from the dorsolateral prefrontal cortex in 179 CH brains, we tested the cis- and trans-effects of AD-associated CGS on brain DNA methylation to mRNA expression. For the genes with significant cis- and trans-effects, we investigated their enriched pathways. We identified six genetic loci in CH with CGS dosage associated with AD at genome-wide significance levels: <i>ADAM20</i> (Score = 55.19, <i>P</i> = 4.06 × 10<sup>–8</sup>), the intergenic region between <i>VRTN</i> and <i>SYNDIG1L</i> (Score = − 37.67, <i>P</i> = 2.25 × 10<sup>–9</sup>), <i>SPG7</i> (16q24.3) (Score = 40.51, <i>P</i> = 2.23 × 10<sup>–8</sup>), <i>PVRL2</i> (Score = 125.86, <i>P</i> = 1.64 × 10<sup>–9</sup>), <i>TOMM40</i> (Score = − 18.58, <i>P</i> = 4.61 × 10<sup>–8</sup>), and <i>APOE</i> (Score = 75.12, <i>P</i> = 7.26 × 10<sup>–26</sup>). CGSes in <i>PVRL2</i> and <i>APOE</i> were also significant in NHW. Except for <i>ADAM20</i>, CGSes in the other five loci were associated with CH brain methylation levels (mQTLs) and CGSes in <i>SPG7, PVRL2,</i> and <i>APOE</i> were also mQTLs in NHW. Except for <i>SYNDIG1L</i> (<i>P</i> = 0.08), brain methylation levels in the other five loci affected downstream mRNA expression in CH (<i>P</i> &lt; 0.05), and methylation at <i>VRTN</i> and <i>TOMM40</i> were also associated with mRNA expression in NHW. Gene expression in these six loci were also regulated by CpG sites in genes that were enriched in the neuron projection and glutamatergic synapse pathways (FDR &lt; 0.05). DNA methylation at all six loci and mRNA expression of <i>SYNDIG1</i> and <i>TOMM40</i> were significantly associated with Braak Stage in CH. In summary, we identified six CpG-related genetic loci associated with AD in CH, harboring both genetic and epigenetic risks. However, their downstream effects on mRNA expression maybe ethnic specific and different from NHW.</p></div>","PeriodicalId":7012,"journal":{"name":"Acta Neuropathologica","volume":"148 1","pages":""},"PeriodicalIF":9.3,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11343944/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142034912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FGFR1 wild-type rosette-forming glioneuronal tumours FGFR1 野生型玫瑰花状胶质细胞瘤
IF 9.3 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-08-21 DOI: 10.1007/s00401-024-02779-x
Mégane Le Quang, Aude Trinquet, Aurore Siegfried, Amaury de Barros, Luc Bauchet, Sam Ng, Vincent Jecko, Guillaume Chotard, Morgan Ollivier, Gilles Adam, Fabrice Bonneville, Julien Masliah-Planchon, Yvan Nicaise, Clémentine Decamps, Valérie Rigau, Emmanuelle Uro-Coste
{"title":"FGFR1 wild-type rosette-forming glioneuronal tumours","authors":"Mégane Le Quang,&nbsp;Aude Trinquet,&nbsp;Aurore Siegfried,&nbsp;Amaury de Barros,&nbsp;Luc Bauchet,&nbsp;Sam Ng,&nbsp;Vincent Jecko,&nbsp;Guillaume Chotard,&nbsp;Morgan Ollivier,&nbsp;Gilles Adam,&nbsp;Fabrice Bonneville,&nbsp;Julien Masliah-Planchon,&nbsp;Yvan Nicaise,&nbsp;Clémentine Decamps,&nbsp;Valérie Rigau,&nbsp;Emmanuelle Uro-Coste","doi":"10.1007/s00401-024-02779-x","DOIUrl":"10.1007/s00401-024-02779-x","url":null,"abstract":"","PeriodicalId":7012,"journal":{"name":"Acta Neuropathologica","volume":"148 1","pages":""},"PeriodicalIF":9.3,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00401-024-02779-x.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142013840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe neurodegeneration in brains of transgenic rats producing human tau prions 产生人类 tau 朊病毒的转基因大鼠大脑出现严重的神经变性。
IF 9.3 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-08-20 DOI: 10.1007/s00401-024-02771-5
Jacob Ayers, T. Peter Lopez, Ian T. Steele, Abby Oehler, Rigo Roman-Albarran, Elisa Cleveland, Alex Chong, George A. Carlson, Carlo Condello, Stanley B. Prusiner

Both wild-type and mutant tau proteins can misfold into prions and self-propagate in the central nervous system of animals and people. To extend the work of others, we investigated the molecular basis of tau prion–mediated neurodegeneration in transgenic (Tg) rats expressing mutant human tau (P301S); this line of Tg rats is denoted Tg12099. We used the rat Prnp promoter to drive the overexpression of mutant tau (P301S) in the human 0N4R isoform. In Tg12099(+/+) rats homozygous for the transgene, ubiquitous expression of mutant human tau resulted in the progressive accumulation of phosphorylated tau inclusions, including silver-positive tangles in the frontal cortices and limbic system. Signs of central nervous system dysfunction were found in terminal Tg12099(+/+) rats exhibiting severe neurodegeneration and profound atrophy of the amygdala and piriform cortex. The greatest increases in tau prion activity were found in the corticolimbic structures. In contrast to the homozygous Tg12099(+/+) rats, we found lower levels of mutant tau in the hemizygous rats, resulting in few neuropathologic changes up to 2 years of age. Notably, these hemizygous rats could be infected by intracerebral inoculation with recombinant tau fibrils or precipitated tau prions from the brain homogenates of sick, aged homozygous Tg12099(+/+) rats. Our studies argue that the regional propagation of tau prions and neurodegeneration in the Tg12099 rats resembles that found in human primary tauopathies. These findings seem likely to advance our understanding of human tauopathies and may lead to effective therapeutics for Alzheimer’s disease and other tau prion disorders.

野生型和突变型tau蛋白都能错误折叠成朊病毒,并在动物和人的中枢神经系统中自我繁殖。为了扩展其他人的研究,我们在表达突变型人类 tau 蛋白(P301S)的转基因(Tg)大鼠中研究了 tau 蛋白朊病毒介导的神经退行性变的分子基础。我们使用大鼠 Prnp 启动子来驱动人类 0N4R 异构体中突变 tau(P301S)的过表达。在转基因Tg12099(+/+)同源大鼠中,突变型人类tau的普遍表达导致磷酸化tau内含物的逐渐积累,包括额叶皮质和边缘系统中的银阳性缠结。Tg12099(+/+)末期大鼠出现了中枢神经系统功能障碍的迹象,表现出严重的神经变性以及杏仁核和梨状皮层的深度萎缩。皮质边缘结构中的 tau 蛋白朊病毒活性增幅最大。与同基因 Tg12099(+/+)大鼠相比,我们发现半杂合子大鼠的突变 tau 含量较低,因此在 2 岁前神经病理学变化很小。值得注意的是,这些半杂合子大鼠可以通过脑内接种重组tau纤维或从患病、年老的同源Tg12099(+/+)大鼠脑匀浆中析出的tau朊病毒而感染。我们的研究表明,Tg12099大鼠体内tau朊病毒的区域性传播和神经变性与人类原发性tau病的情况相似。这些发现似乎有可能促进我们对人类tau病的了解,并有可能为阿尔茨海默病和其他tau朊病毒疾病带来有效的治疗方法。
{"title":"Severe neurodegeneration in brains of transgenic rats producing human tau prions","authors":"Jacob Ayers,&nbsp;T. Peter Lopez,&nbsp;Ian T. Steele,&nbsp;Abby Oehler,&nbsp;Rigo Roman-Albarran,&nbsp;Elisa Cleveland,&nbsp;Alex Chong,&nbsp;George A. Carlson,&nbsp;Carlo Condello,&nbsp;Stanley B. Prusiner","doi":"10.1007/s00401-024-02771-5","DOIUrl":"10.1007/s00401-024-02771-5","url":null,"abstract":"<div><p>Both wild-type and mutant tau proteins can misfold into prions and self-propagate in the central nervous system of animals and people. To extend the work of others, we investigated the molecular basis of tau prion–mediated neurodegeneration in transgenic (Tg) rats expressing mutant human tau (P301S); this line of Tg rats is denoted Tg12099. We used the rat <i>Prnp</i> promoter to drive the overexpression of mutant tau (P301S) in the human 0N4R isoform. In Tg12099(+/+) rats homozygous for the transgene, ubiquitous expression of mutant human tau resulted in the progressive accumulation of phosphorylated tau inclusions, including silver-positive tangles in the frontal cortices and limbic system. Signs of central nervous system dysfunction were found in terminal Tg12099(+/+) rats exhibiting severe neurodegeneration and profound atrophy of the amygdala and piriform cortex. The greatest increases in tau prion activity were found in the corticolimbic structures. In contrast to the homozygous Tg12099(+/+) rats, we found lower levels of mutant tau in the hemizygous rats, resulting in few neuropathologic changes up to 2 years of age. Notably, these hemizygous rats could be infected by intracerebral inoculation with recombinant tau fibrils or precipitated tau prions from the brain homogenates of sick, aged homozygous Tg12099(+/+) rats. Our studies argue that the regional propagation of tau prions and neurodegeneration in the Tg12099 rats resembles that found in human primary tauopathies. These findings seem likely to advance our understanding of human tauopathies and may lead to effective therapeutics for Alzheimer’s disease and other tau prion disorders.</p></div>","PeriodicalId":7012,"journal":{"name":"Acta Neuropathologica","volume":"148 1","pages":""},"PeriodicalIF":9.3,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11333523/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142003326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases 神经退行性疾病死后视网膜的神经病理学特征。
IF 9.3 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-08-19 DOI: 10.1007/s00401-024-02769-z
Frederique J. Hart de Ruyter, Manon J. A. P. Evers, Tjado H. J. Morrema, Anke A. Dijkstra, Jurre den Haan, Jos W. R. Twisk, Johannes F. de Boer, Philip Scheltens, Femke H. Bouwman, Frank D. Verbraak, Annemieke J. Rozemuller, Jeroen J. M. Hoozemans
<div><p>The retina is increasingly recognised as a potential source of biomarkers for neurodegenerative diseases. Hallmark protein aggregates in the retinal neuronal tissue could be imaged through light non-invasively. Post-mortem studies have already shown the presence of specific hallmark proteins in Alzheimer’s disease, primary tauopathies, synucleinopathies and frontotemporal lobar degeneration. This study aims to assess proteinopathy in a post-mortem cohort with different neurodegenerative diseases and assess the presence of the primary pathology in the retina. Post-mortem eyes were collected in collaboration with the Netherlands Brain Bank from donors with Alzheimer’s disease (<i>n</i> = 17), primary tauopathies (<i>n</i> = 8), synucleinopathies (<i>n</i> = 27), frontotemporal lobar degeneration (<i>n</i> = 8), mixed pathology (<i>n</i> = 11), other neurodegenerative diseases (<i>n</i> = 6), and cognitively normal controls (<i>n</i> = 25). Multiple cross sections of the retina and optic nerve tissue were immunostained using antibodies against pTau Ser202/Thr205 (AT8), amyloid-beta (4G8), alpha-synuclein (LB509), pTDP-43 Ser409/410 and p62-lck ligand (p62) and were assessed for the presence of aggregates and inclusions. pTau pathology was observed as a diffuse signal in Alzheimer’s disease, primary tauopathies and controls with Alzheimer’s disease neuropathological changes. Amyloid-beta was observed in the vessel wall and as cytoplasmic granular deposits in all groups. Alpha-synuclein pathology was observed as Lewy neurites in the retina in synucleinopathies associated with Lewy pathology and as oligodendroglial cytoplasmic inclusions in the optic nerve in multiple system atrophy. Anti-pTDP-43 generally showed typical neuronal cytoplasmic inclusion bodies in cases with frontotemporal lobar degeneration with TDP-43 and also in cases with later stages of limbic-associated TDP-43 encephalopathy. P62 showed inclusion bodies similar to those seen with anti-pTDP-43. Furthermore, pTau and alpha-synuclein pathology were significantly associated with increasing Braak stages for neurofibrillary tangles and Lewy bodies, respectively. Mixed pathology cases in this cohort consisted of cases (<i>n</i> = 6) with high Braak LB stages (> 4) and low or moderate AD pathology, high AD pathology (<i>n</i> = 1, Braak NFT 6, Thal phase 5) with moderate LB pathology, or a combination of low/moderate scores for different pathology scores in the brain (<i>n</i> = 4). There were no cases with advanced co-pathologies. In seven cases with Braak LB ≥ 4, LB pathology was observed in the retina, while tau pathology in the retina in the mixed pathology group (<i>n</i> = 11) could not be observed. From this study, we conclude that the retina reflects the presence of the major hallmark proteins associated with neurodegenerative diseases. Although low or moderate levels of copathology were found in the brains of most cases, the retina primarily manifested protein aggregates
视网膜越来越被认为是神经退行性疾病生物标志物的潜在来源。视网膜神经元组织中的标志蛋白聚集体可以通过光线进行无创成像。死后研究已经表明,在阿尔茨海默病、原发性牛磺酸病、突触核蛋白病和额颞叶变性中存在特定的标志蛋白。本研究旨在评估患有不同神经退行性疾病的尸检组群中的蛋白病变,并评估视网膜中是否存在原发性病变。研究人员与荷兰脑库合作,从阿尔茨海默病(17 人)、原发性牛磺酸病(8 人)、突触核蛋白病(27 人)、额颞叶变性(8 人)、混合病理(11 人)、其他神经退行性疾病(6 人)和认知正常对照组(25 人)的供体中收集了死后眼球。使用针对 pTau Ser202/Thr205 (AT8)、淀粉样蛋白-β (4G8)、α-突触核蛋白 (LB509)、pTDP-43 Ser409/410 和 p62-lck 配体 (p62) 的抗体对视网膜和视神经组织的多个横切面进行免疫染色,并评估是否存在聚集体和内含物。在阿尔茨海默病、原发性陶陶病和阿尔茨海默病神经病理改变对照组中观察到 pTau 病理变化呈弥漫性信号。淀粉样蛋白-β可在血管壁上观察到,在所有组别中均呈细胞质颗粒状沉积。α-突触核蛋白病理变化在突触核蛋白病伴有路易病理变化的视网膜中表现为路易神经元,在多系统萎缩的视神经中表现为少突胶质细胞质包涵体。在额颞叶变性伴 TDP-43 的病例中,以及在肢端相关 TDP-43 脑病晚期病例中,抗 pTDP-43 通常显示典型的神经元胞浆包涵体。P62 显示的包涵体与抗 pTDP-43 的包涵体相似。此外,pTau和α-突触核蛋白病理学分别与神经纤维缠结和路易体的布拉克分期的增加有显著关联。该队列中的混合病理病例包括具有高Braak LB分期(> 4)和低或中度AD病理的病例(n = 6)、高AD病理(n = 1,Braak NFT 6,Thal phase 5)和中度LB病理的病例,或大脑中不同病理评分的低/中度组合(n = 4)。没有晚期合并病理的病例。在 Braak LB≥4 的 7 个病例中,视网膜中观察到了 LB 病变,而混合病理组(n = 11)视网膜中无法观察到 tau 病变。通过这项研究,我们得出结论:视网膜反映了与神经退行性疾病相关的主要标志蛋白的存在。虽然在大多数病例的大脑中发现了低度或中度的共病理学,但视网膜主要表现为与主要神经退行性疾病相关的蛋白质聚集。这些研究结果表明,利用适当的视网膜成像技术,视网膜生物标记物有可能成为诊断主要脑神经退行性疾病的高度准确的指标。
{"title":"Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases","authors":"Frederique J. Hart de Ruyter,&nbsp;Manon J. A. P. Evers,&nbsp;Tjado H. J. Morrema,&nbsp;Anke A. Dijkstra,&nbsp;Jurre den Haan,&nbsp;Jos W. R. Twisk,&nbsp;Johannes F. de Boer,&nbsp;Philip Scheltens,&nbsp;Femke H. Bouwman,&nbsp;Frank D. Verbraak,&nbsp;Annemieke J. Rozemuller,&nbsp;Jeroen J. M. Hoozemans","doi":"10.1007/s00401-024-02769-z","DOIUrl":"10.1007/s00401-024-02769-z","url":null,"abstract":"&lt;div&gt;&lt;p&gt;The retina is increasingly recognised as a potential source of biomarkers for neurodegenerative diseases. Hallmark protein aggregates in the retinal neuronal tissue could be imaged through light non-invasively. Post-mortem studies have already shown the presence of specific hallmark proteins in Alzheimer’s disease, primary tauopathies, synucleinopathies and frontotemporal lobar degeneration. This study aims to assess proteinopathy in a post-mortem cohort with different neurodegenerative diseases and assess the presence of the primary pathology in the retina. Post-mortem eyes were collected in collaboration with the Netherlands Brain Bank from donors with Alzheimer’s disease (&lt;i&gt;n&lt;/i&gt; = 17), primary tauopathies (&lt;i&gt;n&lt;/i&gt; = 8), synucleinopathies (&lt;i&gt;n&lt;/i&gt; = 27), frontotemporal lobar degeneration (&lt;i&gt;n&lt;/i&gt; = 8), mixed pathology (&lt;i&gt;n&lt;/i&gt; = 11), other neurodegenerative diseases (&lt;i&gt;n&lt;/i&gt; = 6), and cognitively normal controls (&lt;i&gt;n&lt;/i&gt; = 25). Multiple cross sections of the retina and optic nerve tissue were immunostained using antibodies against pTau Ser202/Thr205 (AT8), amyloid-beta (4G8), alpha-synuclein (LB509), pTDP-43 Ser409/410 and p62-lck ligand (p62) and were assessed for the presence of aggregates and inclusions. pTau pathology was observed as a diffuse signal in Alzheimer’s disease, primary tauopathies and controls with Alzheimer’s disease neuropathological changes. Amyloid-beta was observed in the vessel wall and as cytoplasmic granular deposits in all groups. Alpha-synuclein pathology was observed as Lewy neurites in the retina in synucleinopathies associated with Lewy pathology and as oligodendroglial cytoplasmic inclusions in the optic nerve in multiple system atrophy. Anti-pTDP-43 generally showed typical neuronal cytoplasmic inclusion bodies in cases with frontotemporal lobar degeneration with TDP-43 and also in cases with later stages of limbic-associated TDP-43 encephalopathy. P62 showed inclusion bodies similar to those seen with anti-pTDP-43. Furthermore, pTau and alpha-synuclein pathology were significantly associated with increasing Braak stages for neurofibrillary tangles and Lewy bodies, respectively. Mixed pathology cases in this cohort consisted of cases (&lt;i&gt;n&lt;/i&gt; = 6) with high Braak LB stages (&gt; 4) and low or moderate AD pathology, high AD pathology (&lt;i&gt;n&lt;/i&gt; = 1, Braak NFT 6, Thal phase 5) with moderate LB pathology, or a combination of low/moderate scores for different pathology scores in the brain (&lt;i&gt;n&lt;/i&gt; = 4). There were no cases with advanced co-pathologies. In seven cases with Braak LB ≥ 4, LB pathology was observed in the retina, while tau pathology in the retina in the mixed pathology group (&lt;i&gt;n&lt;/i&gt; = 11) could not be observed. From this study, we conclude that the retina reflects the presence of the major hallmark proteins associated with neurodegenerative diseases. Although low or moderate levels of copathology were found in the brains of most cases, the retina primarily manifested protein aggregates","PeriodicalId":7012,"journal":{"name":"Acta Neuropathologica","volume":"148 1","pages":""},"PeriodicalIF":9.3,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11333524/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142003325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microglia contribute to polyG-dependent neurodegeneration in neuronal intranuclear inclusion disease 小胶质细胞有助于神经元核内包涵体病的多聚酶依赖性神经变性。
IF 9.3 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-08-16 DOI: 10.1007/s00401-024-02776-0
Shaoping Zhong, Yangye Lian, Binbin Zhou, Ruiqing Ren, Lewei Duan, Yuyin Pan, Yuchen Gong, Xiaoling Wu, Dengfeng Cheng, Puming Zhang, Boxun Lu, Xin Wang, Jing Ding

Neuronal intranuclear inclusion disease (NIID) is a neurodegenerative disorder caused by the expansion of GGC trinucleotide repeats in NOTCH2NLC gene. Despite identifying uN2CpolyG, a toxic polyglycine (polyG) protein translated by expanded GGC repeats, the exact pathogenic mechanisms of NIID remain unclear. In this study, we investigated the role of polyG by expressing various forms of NOTCH2NLC in mice: the wild-type, the expanded form with 100 GGC repeats (either translating or not translating into uN2CpolyG), and the mutated form that encodes a pure polyG without GGC-repeat RNA and the C-terminal stretch (uN2CpolyG-dCT). Both uN2CpolyG and uN2CpolyG-dCT induced the formation of inclusions composed by filamentous materials and resulted in neurodegenerative phenotypes in mice, including impaired motor and cognitive performance, shortened lifespan, and pathologic lesions such as white-matter lesions, microgliosis, and astrogliosis. In contrast, expressing GGC-repeat RNA alone was non-pathogenic. Through bulk and single-nuclei RNA sequencing, we identified common molecular signatures linked to the expression of uN2CpolyG and uN2CpolyG-dCT, particularly the upregulation of inflammation and microglia markers, and the downregulation of immediate early genes and splicing factors. Importantly, microglia-mediated inflammation was visualized in NIID patients using positron emission tomography, correlating with levels of white-matter atrophy. Furthermore, microglia ablation ameliorated neurodegenerative phenotypes and transcriptional alterations in uN2CpolyG-expressing mice but did not affect polyG inclusions. Together, these results demonstrate that polyG is crucial for the pathogenesis of NIID and highlight the significant role of microglia in polyG-induced neurodegeneration.

神经元核内包涵体病(NIID)是一种由 NOTCH2NLC 基因中 GGC 三核苷酸重复序列扩增引起的神经退行性疾病。尽管发现了uN2CpolyG--一种由扩展的GGC重复序列翻译而来的毒性多甘氨酸(polyG)蛋白,但NIID的确切致病机制仍不清楚。在本研究中,我们通过在小鼠体内表达不同形式的 NOTCH2NLC 来研究 polyG 的作用:野生型、具有 100 个 GGC 重复序列的扩展型(可翻译成或不翻译成 uN2CpolyG)以及编码纯 polyG 的突变型(不含 GGC 重复序列 RNA 和 C 端伸展部分)(uN2CpolyG-dCT)。uN2CpolyG 和 uN2CpolyG-dCT 都会诱导由丝状物质组成的包涵体的形成,并导致小鼠出现神经退行性表型,包括运动和认知能力受损、寿命缩短以及白质病变、微胶质细胞病变和星形胶质细胞病变等病理病变。相比之下,单独表达 GGC 重复 RNA 并不致病。通过大量和单核 RNA 测序,我们发现了与 uN2CpolyG 和 uN2CpolyG-dCT 表达相关的共同分子特征,特别是炎症和小胶质细胞标志物的上调,以及即刻早期基因和剪接因子的下调。重要的是,利用正电子发射断层扫描可观察到 NIID 患者由小胶质细胞介导的炎症,这与白质萎缩的程度相关。此外,小胶质细胞消融可改善 uN2CpolyG 表达小鼠的神经退行性表型和转录改变,但不会影响 polyG 包涵体。总之,这些结果证明了polyG对NIID的发病机制至关重要,并强调了小胶质细胞在polyG诱导的神经退行性变中的重要作用。
{"title":"Microglia contribute to polyG-dependent neurodegeneration in neuronal intranuclear inclusion disease","authors":"Shaoping Zhong,&nbsp;Yangye Lian,&nbsp;Binbin Zhou,&nbsp;Ruiqing Ren,&nbsp;Lewei Duan,&nbsp;Yuyin Pan,&nbsp;Yuchen Gong,&nbsp;Xiaoling Wu,&nbsp;Dengfeng Cheng,&nbsp;Puming Zhang,&nbsp;Boxun Lu,&nbsp;Xin Wang,&nbsp;Jing Ding","doi":"10.1007/s00401-024-02776-0","DOIUrl":"10.1007/s00401-024-02776-0","url":null,"abstract":"<div><p>Neuronal intranuclear inclusion disease (NIID) is a neurodegenerative disorder caused by the expansion of GGC trinucleotide repeats in <i>NOTCH2NLC</i> gene. Despite identifying uN2CpolyG, a toxic polyglycine (polyG) protein translated by expanded GGC repeats, the exact pathogenic mechanisms of NIID remain unclear. In this study, we investigated the role of polyG by expressing various forms of <i>NOTCH2NLC</i> in mice: the wild-type, the expanded form with 100 GGC repeats (either translating or not translating into uN2CpolyG), and the mutated form that encodes a pure polyG without GGC-repeat RNA and the C-terminal stretch (uN2CpolyG-dCT). Both uN2CpolyG and uN2CpolyG-dCT induced the formation of inclusions composed by filamentous materials and resulted in neurodegenerative phenotypes in mice, including impaired motor and cognitive performance, shortened lifespan, and pathologic lesions such as white-matter lesions, microgliosis, and astrogliosis. In contrast, expressing GGC-repeat RNA alone was non-pathogenic. Through bulk and single-nuclei RNA sequencing, we identified common molecular signatures linked to the expression of uN2CpolyG and uN2CpolyG-dCT, particularly the upregulation of inflammation and microglia markers, and the downregulation of immediate early genes and splicing factors. Importantly, microglia-mediated inflammation was visualized in NIID patients using positron emission tomography, correlating with levels of white-matter atrophy. Furthermore, microglia ablation ameliorated neurodegenerative phenotypes and transcriptional alterations in uN2CpolyG-expressing mice but did not affect polyG inclusions. Together, these results demonstrate that polyG is crucial for the pathogenesis of NIID and highlight the significant role of microglia in polyG-induced neurodegeneration.</p></div>","PeriodicalId":7012,"journal":{"name":"Acta Neuropathologica","volume":"148 1","pages":""},"PeriodicalIF":9.3,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00401-024-02776-0.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141987141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to L. Lucchino et al. on commentary on “Histologic correlates of “Choroidal Abnormalities” in Neurofibromatosis type 1” 回复 L. Lucchino 等人关于 "1 型神经纤维瘤病'脉络膜异常'的组织学相关性 "的评论。
IF 9.3 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-08-16 DOI: 10.1007/s00401-024-02782-2
Anat O. Stemmer-Rachamimov, Liana Kozanno, Scott R. Plotkin, Justin T. Jordan, Joseph F. Rizzo 3rd
{"title":"Reply to L. Lucchino et al. on commentary on “Histologic correlates of “Choroidal Abnormalities” in Neurofibromatosis type 1”","authors":"Anat O. Stemmer-Rachamimov,&nbsp;Liana Kozanno,&nbsp;Scott R. Plotkin,&nbsp;Justin T. Jordan,&nbsp;Joseph F. Rizzo 3rd","doi":"10.1007/s00401-024-02782-2","DOIUrl":"10.1007/s00401-024-02782-2","url":null,"abstract":"","PeriodicalId":7012,"journal":{"name":"Acta Neuropathologica","volume":"148 1","pages":""},"PeriodicalIF":9.3,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00401-024-02782-2.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141987142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Key features of choroidal abnormalities in neurofibromatosis type 1, a commentary on “Histologic correlates of “choroidal abnormalities” in neurofibromatosis type 1 (NF1)” 1 型神经纤维瘤病脉络膜异常的主要特征,对《1 型神经纤维瘤病 (NF1) 中 "脉络膜异常 "的组织学相关性》的评论。
IF 9.3 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-08-16 DOI: 10.1007/s00401-024-02783-1
Luca Lucchino, Fabiana Mallone, Magda Gharbiya, Ludovico Alisi
{"title":"Key features of choroidal abnormalities in neurofibromatosis type 1, a commentary on “Histologic correlates of “choroidal abnormalities” in neurofibromatosis type 1 (NF1)”","authors":"Luca Lucchino,&nbsp;Fabiana Mallone,&nbsp;Magda Gharbiya,&nbsp;Ludovico Alisi","doi":"10.1007/s00401-024-02783-1","DOIUrl":"10.1007/s00401-024-02783-1","url":null,"abstract":"","PeriodicalId":7012,"journal":{"name":"Acta Neuropathologica","volume":"148 1","pages":""},"PeriodicalIF":9.3,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00401-024-02783-1.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141987180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cryo-EM structures of cotton wool plaques’ amyloid β and of tau filaments in dominantly inherited Alzheimer disease 显性遗传阿尔茨海默病中棉絮斑块淀粉样β和tau丝的冷冻电子显微镜结构。
IF 9.3 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-08-15 DOI: 10.1007/s00401-024-02786-y
Md Rejaul Hoq, Anllely Fernandez, Frank S. Vago, Grace I. Hallinan, Sakshibeedu R. Bharath, Daoyi Li, Kadir A. Ozcan, Holly J. Garringer, Wen Jiang, Ruben Vidal, Bernardino Ghetti

Cotton wool plaques (CWPs) have been described as features of the neuropathologic phenotype of dominantly inherited Alzheimer disease (DIAD) caused by some missense and deletion mutations in the presenilin 1 (PSEN1) gene. CWPs are round, eosinophilic amyloid-β (Aβ) plaques that lack an amyloid core and are recognizable, but not fluorescent, in Thioflavin S (ThS) preparations. Amino-terminally truncated and post-translationally modified Aβ peptide species are the main component of CWPs. Tau immunopositive neurites may be present in CWPs. In addition, neurofibrillary tangles coexist with CWPs. Herein, we report the structure of Aβ and tau filaments isolated from brain tissue of individuals affected by DIAD caused by the PSEN1 V261I and A431E mutations, with the CWP neuropathologic phenotype. CWPs are predominantly composed of type I Aβ filaments present in two novel arrangements, type Ic and type Id; additionally, CWPs contain type I and type Ib Aβ filaments. Tau filaments have the AD fold, which has been previously reported in sporadic AD and DIAD. The formation of type Ic and type Id Aβ filaments may be the basis for the phenotype of CWPs. Our data are relevant for the development of PET imaging methodologies to best detect CWPs in DIAD.

棉絮斑(CWPs)被描述为显性遗传性阿尔茨海默病(DIAD)神经病理学表型的特征,该病是由 Presenilin 1(PSEN1)基因的某些错义和缺失突变引起的。CWPs是缺乏淀粉样核心的圆形嗜酸性淀粉样-β(Aβ)斑块,在硫黄素S(ThS)制剂中可被识别,但无荧光。氨基酸末端截短和翻译后修饰的 Aβ 肽是 CWPs 的主要成分。CWPs 中可能存在 Tau 免疫阳性神经元。此外,神经纤维缠结也与 CWPs 共存。在此,我们报告了从因 PSEN1 V261I 和 A431E 突变导致的 DIAD 患者脑组织中分离出的 Aβ 和 tau 纤维的结构,这些患者具有 CWP 神经病理学表型。CWPs主要由I型Aβ丝组成,并以Ic型和Id型两种新的排列方式存在;此外,CWPs还含有I型和Ib型Aβ丝。Tau丝具有AD折叠,这在散发性AD和DIAD中已有报道。Ic 型和 Id 型 Aβ 细丝的形成可能是 CWPs 表型的基础。我们的数据与 PET 成像方法的发展相关,以最好地检测 DIAD 中的 CWPs。
{"title":"Cryo-EM structures of cotton wool plaques’ amyloid β and of tau filaments in dominantly inherited Alzheimer disease","authors":"Md Rejaul Hoq,&nbsp;Anllely Fernandez,&nbsp;Frank S. Vago,&nbsp;Grace I. Hallinan,&nbsp;Sakshibeedu R. Bharath,&nbsp;Daoyi Li,&nbsp;Kadir A. Ozcan,&nbsp;Holly J. Garringer,&nbsp;Wen Jiang,&nbsp;Ruben Vidal,&nbsp;Bernardino Ghetti","doi":"10.1007/s00401-024-02786-y","DOIUrl":"10.1007/s00401-024-02786-y","url":null,"abstract":"<div><p>Cotton wool plaques (CWPs) have been described as features of the neuropathologic phenotype of dominantly inherited Alzheimer disease (DIAD) caused by some missense and deletion mutations in the presenilin 1 (<i>PSEN1</i>) gene. CWPs are round, eosinophilic amyloid-β (Aβ) plaques that lack an amyloid core and are recognizable, but not fluorescent, in Thioflavin S (ThS) preparations. Amino-terminally truncated and post-translationally modified Aβ peptide species are the main component of CWPs. Tau immunopositive neurites may be present in CWPs. In addition, neurofibrillary tangles coexist with CWPs. Herein, we report the structure of Aβ and tau filaments isolated from brain tissue of individuals affected by DIAD caused by the <i>PSEN1 V261I</i> and <i>A431E</i> mutations, with the CWP neuropathologic phenotype. CWPs are predominantly composed of type I Aβ filaments present in two novel arrangements, type Ic and type Id; additionally, CWPs contain type I and type Ib Aβ filaments. Tau filaments have the AD fold, which has been previously reported in sporadic AD and DIAD. The formation of type Ic and type Id Aβ filaments may be the basis for the phenotype of CWPs. Our data are relevant for the development of PET imaging methodologies to best detect CWPs in DIAD.</p></div>","PeriodicalId":7012,"journal":{"name":"Acta Neuropathologica","volume":"148 1","pages":""},"PeriodicalIF":9.3,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11327195/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141987179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current insights and assumptions on α-synuclein in Lewy body disease 目前对路易体疾病中α-突触核蛋白的认识和假设。
IF 9.3 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-08-14 DOI: 10.1007/s00401-024-02781-3
Rehana K. Leak, Rachel N. Clark, Muslim Abbas, Fei Xu, Jeffrey L. Brodsky, Jun Chen, Xiaoming Hu, Kelvin C. Luk

Lewy body disorders are heterogeneous neurological conditions defined by intracellular inclusions composed of misshapen α-synuclein protein aggregates. Although α-synuclein aggregates are only one component of inclusions and not strictly coupled to neurodegeneration, evidence suggests they seed the propagation of Lewy pathology within and across cells. Genetic mutations, genomic multiplications, and sequence polymorphisms of the gene encoding α-synuclein are also causally linked to Lewy body disease. In nonfamilial cases of Lewy body disease, the disease trigger remains unidentified but may range from industrial/agricultural toxicants and natural sources of poisons to microbial pathogens. Perhaps due to these peripheral exposures, Lewy inclusions appear at early disease stages in brain regions connected with cranial nerves I and X, which interface with inhaled and ingested environmental elements in the nasal or gastrointestinal cavities. Irrespective of its identity, a stealthy disease trigger most likely shifts soluble α-synuclein (directly or indirectly) into insoluble, cross-β-sheet aggregates. Indeed, β-sheet-rich self-replicating α-synuclein multimers reside in patient plasma, cerebrospinal fluid, and other tissues, and can be subjected to α-synuclein seed amplification assays. Thus, clinicians should be able to capitalize on α-synuclein seed amplification assays to stratify patients into potential responders versus non-responders in future clinical trials of α-synuclein targeted therapies. Here, we briefly review the current understanding of α-synuclein in Lewy body disease and speculate on pathophysiological processes underlying the potential transmission of α-synucleinopathy across the neuraxis.

路易体疾病是一种由畸形的α-突触核蛋白聚集体构成的细胞内包涵体所定义的神经系统疾病。虽然α-突触核蛋白聚集体只是内含物的一个组成部分,与神经变性并无严格关联,但有证据表明,它们是路易体病理学在细胞内和细胞间传播的种子。α-突触核蛋白编码基因的基因突变、基因组增殖和序列多态性也与路易体疾病有因果关系。在路易体病的非家族病例中,疾病的诱因仍未确定,但可能包括工业/农业毒物、天然毒物来源和微生物病原体。也许是由于这些外周接触,路易包涵体在疾病早期出现在与颅神经 I 和 X 相连的脑区,这些脑区与鼻腔或胃肠道中吸入和摄入的环境因素相接。无论其身份如何,隐性疾病诱因最有可能(直接或间接)将可溶的α-突触核蛋白转变为不溶的、交叉β片状聚集体。事实上,患者血浆、脑脊液和其他组织中都存在富含β片的自我复制α-突触核蛋白多聚体,并可进行α-突触核蛋白种子扩增试验。因此,在未来的α-突触核蛋白靶向疗法临床试验中,临床医生应能利用α-突触核蛋白种子扩增检测将患者分为潜在应答者和非应答者。在此,我们简要回顾了目前对路易体病中α-突触核蛋白的认识,并推测了α-突触核蛋白病可能在神经轴中传播的病理生理过程。
{"title":"Current insights and assumptions on α-synuclein in Lewy body disease","authors":"Rehana K. Leak,&nbsp;Rachel N. Clark,&nbsp;Muslim Abbas,&nbsp;Fei Xu,&nbsp;Jeffrey L. Brodsky,&nbsp;Jun Chen,&nbsp;Xiaoming Hu,&nbsp;Kelvin C. Luk","doi":"10.1007/s00401-024-02781-3","DOIUrl":"10.1007/s00401-024-02781-3","url":null,"abstract":"<div><p>Lewy body disorders are heterogeneous neurological conditions defined by intracellular inclusions composed of misshapen α-synuclein protein aggregates. Although α-synuclein aggregates are only one component of inclusions and not strictly coupled to neurodegeneration, evidence suggests they seed the propagation of Lewy pathology within and across cells. Genetic mutations, genomic multiplications, and sequence polymorphisms of the gene encoding α-synuclein are also causally linked to Lewy body disease. In nonfamilial cases of Lewy body disease, the disease trigger remains unidentified but may range from industrial/agricultural toxicants and natural sources of poisons to microbial pathogens. Perhaps due to these peripheral exposures, Lewy inclusions appear at early disease stages in brain regions connected with cranial nerves I and X, which interface with inhaled and ingested environmental elements in the nasal or gastrointestinal cavities. Irrespective of its identity, a stealthy disease trigger most likely shifts soluble α-synuclein (directly or indirectly) into insoluble, cross-β-sheet aggregates. Indeed, β-sheet-rich self-replicating α-synuclein multimers reside in patient plasma, cerebrospinal fluid, and other tissues, and can be subjected to α-synuclein seed amplification assays. Thus, clinicians should be able to capitalize on α-synuclein seed amplification assays to stratify patients into potential responders <i>versus</i> non-responders in future clinical trials of α-synuclein targeted therapies. Here, we briefly review the current understanding of α-synuclein in Lewy body disease and speculate on pathophysiological processes underlying the potential transmission of α-synucleinopathy across the neuraxis.</p></div>","PeriodicalId":7012,"journal":{"name":"Acta Neuropathologica","volume":"148 1","pages":""},"PeriodicalIF":9.3,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11324801/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141974781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors 中枢神经系统肿瘤中 ASXL1 失活和 H3K27me3 减少。
IF 9.3 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2024-08-14 DOI: 10.1007/s00401-024-02785-z
Kevin Y. Zhang, Megan Parker, Carly Weber-Levine, Anita Kalluri, Ignacio Gonzalez-Gomez, Eric Raabe, Jonathan C. Dudley, Christopher Gocke, Ming-Tseh Lin, Ying Zou, Mohamed Sherief, David O. Kamson, Matthias Holdhoff, Debraj Mukherjee, Victoria Croog, Karisa C. Schreck, Jordina Rincon-Torroella, Chetan Bettegowda, Charles G. Eberhart, Tejus Bale, Calixto-Hope G. Lucas
{"title":"ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors","authors":"Kevin Y. Zhang,&nbsp;Megan Parker,&nbsp;Carly Weber-Levine,&nbsp;Anita Kalluri,&nbsp;Ignacio Gonzalez-Gomez,&nbsp;Eric Raabe,&nbsp;Jonathan C. Dudley,&nbsp;Christopher Gocke,&nbsp;Ming-Tseh Lin,&nbsp;Ying Zou,&nbsp;Mohamed Sherief,&nbsp;David O. Kamson,&nbsp;Matthias Holdhoff,&nbsp;Debraj Mukherjee,&nbsp;Victoria Croog,&nbsp;Karisa C. Schreck,&nbsp;Jordina Rincon-Torroella,&nbsp;Chetan Bettegowda,&nbsp;Charles G. Eberhart,&nbsp;Tejus Bale,&nbsp;Calixto-Hope G. Lucas","doi":"10.1007/s00401-024-02785-z","DOIUrl":"10.1007/s00401-024-02785-z","url":null,"abstract":"","PeriodicalId":7012,"journal":{"name":"Acta Neuropathologica","volume":"148 1","pages":""},"PeriodicalIF":9.3,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11324662/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141974780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Neuropathologica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1